P2606 - Global Early Commercial Manager, Oncologia — Debiopharm
Debiopharm · Lausanne (VD)
Panoramica
In Debiopharm, ogni passo che facciamo è guidato da un unico scopo: migliorare la vita delle persone colpite da cancro e malattie infettive.
In quanto azienda biofarmaceutica svizzera di proprietà privata, siamo guidati dalla scienza, ma soprattutto dalle persone dietro ogni trattamento: i pazienti e le loro famiglie.
Attraverso il nostro esclusivo modello di “solo sviluppo”, portiamo avanti terapie promettenti e le trasformiamo in trattamenti che possono raggiungere coloro che ne hanno più bisogno, più velocemente.
Requisiti principali
- Market Insight Integration: Gather and analyze global market insights from KOLs, advisory boards, and patient organizations to shape product development strategy.
- Strategic Planning: Lead the creation of market-driven disease area strategies and refine Target Out-licensing Profiles (TOP).
- Landscape Assessment: Perform deep dives into market dynamics, patient journeys, and "white space" to drive product positioning and "war gaming" exercises.
- Clinical Collaboration: Partner with Clinical Operations to optimize trial enrollment and retention through targeted recruitment campaigns and investigator engagement.
- Value Proposition: Optimize the Target Product Profile (TPP) to ensure a clearly differentiated competitive advantage and clinical value.
- Stakeholder Management: Build productive relationships across PMO, Medical, Legal, and Regulatory teams to ensure strategic alignment.
- Advocacy & Awareness: Create advocacy plans with medical teams and collaborate with Communications to build early product awareness.
- Business Development Support: Assist the licensing team in assessing business opportunities for new products using market intelligence.
